People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lung Therapeutics, Inc. | — | Pharmaceuticals | Series B | $87.5M | $174.9M | 2019 |
R. A. Session at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside R. A. Session on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Aaron G.L. Fletcher | 1 | 2 |
| William C. Fairey | 1 | 2 |
| Steven Brian Idell | 1 | 1 |
| Aaron Brian Fletcher | 1 | 1 |
| Joseph Brian Woelkers | 1 | 1 |
| Charles C. Garner | 1 | 1 |
| Brian Windsor | 1 | 1 |
| Robert Brian Mills | 1 | 1 |
| Jim Brian Mervis | 1 | 1 |
| James Brian Windsor | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.